P-69 14員環マクロライド抗生物質ランカマイシンの生合成経路(ポスター発表の部)
書誌事項
- タイトル別名
-
- P-69 Biosynthetic pathway of the 14-membered macrolide antibiotic lankamycin(Poster Presentation)
抄録
Lankamycin (2), produced by Streptomyces rochei 7434AN4, is a 14-membered macrolide antibiotic attached with two deoxysugars, L-arcanose and D-chalcose. To reveal the order of glycosylation steps in lankamycin biosynthesis, we carried out gene disruption of two glycosyltransferase genes, Ikm1 and IkmL. The /km/ mutant produced 3-O-L-arcanosyl lankanolide (3), while the IkmL mutant accumulated 8-deoxylankanolide (4). These results indicated that LkmL transfers L-arcanose to the C-3 hydroxyl of 4, while Lkml does D-chalcose to the C-5 hydroxyl of 3. Taking together with previous results of gene disruption of two P450 hydroxylases, we propose the biosynthetic pathway of lankamycin including two hydroxylation and two glycosylation steps. Compound 2 contains a 3-hydroxy-2-butyl side chain at C-13. To analyze the function of IkmE which encodes type-II thioesterase in the lankamycin cluster, we carried out a gene disruption experiment. Disruption of IkmE resulted in a 70% decrease of lankamycin production concomitant with an accumulation of novel lankamycin derivatives (LM-NSO1A and LM-NSO1B), in which the C-13 side chain is replaced by a 1-carboxyethyl group. The biosynthetic origin of 1-carboxyethyl group was confirmed by incorporation of deuterium in [3-2H]3-methyl-2-oxobutyrate (10) into the C-14 position. These results indicate that the biosynthesis of LM-NSO1A and LM-NSO1B starts from isobutyryl CoA in place of (S)-2-methylbutyryl CoA and LkmE removes the aberrantly loaded starter unit and restores lankamycin production.
収録刊行物
-
- 天然有機化合物討論会講演要旨集
-
天然有機化合物討論会講演要旨集 53 (0), 475-480, 2011
天然有機化合物討論会実行委員会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681056809984
-
- NII論文ID
- 110009986581
-
- ISSN
- 24331856
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可